Access

News

Nature 404, 5 (2 March 2000) | doi:10.1038/35003711

NIH tightens up monitoring of gene-therapy mishaps

Paul Smaglik

The US National Institutes of Health (NIH) is telephoning every investigator who has registered a clinical trial in gene therapy, in an expanded effort to track down unreported adverse events. Its results will be made available on the Internet by the end of the year, in a bid to respond to public concerns.